Urology

Medicine and Dentistry

1. Patient 100%
2. Prostate Cancer 40%
3. Inpatient 36%
4. Man 25%
5. Surgery 22%
6. Analysis 21%
7. Clear Cell Renal Cell Carcinoma 21%
8. Prostatectomy 20%
9. Prostate Specific Antigen 15%
10. Age 15%
11. Transitional Cell Carcinoma 15%
12. Neoplasm 14%
13. Follow up 12%
14. Biopsy 12%
15. Bladder 11%
16. Prostate 11%
17. Prostate Hypertrophy 11%
18. Lower Urinary Tract Symptom 10%
19. Survival 10%
20. Symptom 9%
21. Bladder Cancer 9%
22. Gleason Score 9%
23. Cystectomy 8%
24. Serum 8%
25. Partial Nephrectomy 8%
26. Diagnosis 8%
27. Association 8%
28. Overall Survival 8%
29. Disease 8%
30. Recurrent Disease 7%
31. Overactive Bladder 7%
32. Malignant Neoplasm 7%
33. Prognosis 7%
34. Enucleation 7%
35. Hazard Ratio 7%
36. International Prostate Symptom Score 7%
37. Prostate Biopsy 7%
38. Holmium 6%
39. Cancer Specific Survival 6%
40. Biochemical Recurrence 6%
41. Prognostic Factor 6%
42. Urodynamics 6%
43. Kidney Function 6%
44. Child 6%
45. Complication 6%
46. Woman 6%
47. Radical Nephrectomy 6%
48. Evaluation Study 6%
49. Male 5%
50. Kidney 5%
51. Development 5%
52. Stone 5%
53. Nephroureterectomy 5%
54. Combination Therapy 5%
55. Transrectal Ultrasonography 5%
56. Magnetic Resonance Imaging 5%
57. Upper Urinary Tract 5%
58. Health 5%
59. Hospital 5%
60. Multivariate Analysis 5%